Connect with us

Health

What Should Investors Know About 2-Dose COVID Vaccines? – The Motley Fool

A vaccination expert unpacks the challenges presented by a two-dose schedule.

Published

on

post featured image

There is a small amount of data that suggests only one dose of a coronavirus vaccine in a two-dose schedule can provide some protection against the coronavirus. Does this mean that people could safely receive one dose instead of two? Is it too late for investors to start paying attention to companies working on a single-dose vaccine, like Johnson & Johnson(NYSE:JNJ)? Dr. Bruce Gellin of the Sabin Vaccine Institute joined Olivia Zitkus and Corinne Cardina of Fool.com’s Healthcare and Cannabis Bureau…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending